Dechra Pharmaceuticals Plc
Dechra Pharmaceuticals Plc acts as a holding company to all the group's subsidiaries. The company operates through four segments split between pharmaceutical and services. Pharmaceuticals comprises three segments: European Pharmaceuticals, U.S. Pharmaceuticals and Research and Development. The European Pharmaceuticals segment markets and sells licensed branded pharmaceuticals and specialist pet foods to the veterinary profession in Europe. It is a licensed manufacturer of both Dechra's own branded products and products for third party customers. The U.S. Pharmaceuticals segment markets and sells a range of endocrine, ophthalmic, dermatological and equine products in North America. The Research and Development segment develops and licenses Dechra's own branded veterinary product portfolio of novel and generic pharmaceuticals and specialist pet diets. The fourth segment, Services, distributes veterinary products, including pharmaceuticals, specialist pet diets and instruments to veterinary practices within the United Kingdom. It also provides histology, pathology, haematology, chemistry and microbiology services to veterinary practices. The company was founded in June 1997 and is headquartered in Northwich, the United Kingdom.